Viatris (VTRS) Common Equity (2018 - 2026)
Viatris (VTRS) recorded quarterly Common Equity of $14.7 billion in Q1 2026, little changed quarter-over-quarter from $14.7 billion in Q4 2025, and down 6.34% on a YoY basis from $15.7 billion in Q1 2025.
Viatris (VTRS) Common Equity (2018 - 2026) Analysis & Trends
Viatris' Common Equity history runs 9 years deep, the most recent figure standing at $14.7 billion for Q1 2026.
- In Q1 2026, Common Equity fell 6.34% year-over-year to $14.7 billion; the TTM figure through Mar 2026 stood at $14.7 billion (down 6.34% YoY), while the FY2025 annual figure was $14.7 billion, down 21.06% from the prior year.
- Common Equity was $14.7 billion for Q1 2026 at Viatris, roughly flat from $14.7 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $21.1 billion in Q4 2022 to a low of $14.7 billion in Q1 2026.
- Historically, Common Equity has averaged $18.7 billion across 5 years, with a median of $19.8 billion in 2024.
- The sharpest annual moves came in 2023 and 2025: Common Equity climbed 8.78% in 2023, then fell 23.11% in 2025.
- A 5-year view of Common Equity shows it stood at $21.1 billion in 2022, then retreated by 2.87% to $20.5 billion in 2023, then fell by 8.95% to $18.6 billion in 2024, then slipped by 21.06% to $14.7 billion in 2025, then fell by 0.36% to $14.7 billion in 2026.
- The last three Common Equity figures came in at $14.7 billion (Q1 2026), $14.7 billion (Q4 2025), and $15.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.21 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | Viatris | - | - | 1.16 Bn | 14.66 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.66 Bn |
| Dec 31, 2025 | 14.71 Bn |
| Sep 30, 2025 | 15.22 Bn |
| Jun 30, 2025 | 15.57 Bn |
| Mar 31, 2025 | 15.65 Bn |
| Dec 31, 2024 | 18.64 Bn |
| Sep 30, 2024 | 19.79 Bn |
| Jun 30, 2024 | 19.52 Bn |
| Mar 31, 2024 | 20.01 Bn |
| Dec 31, 2023 | 20.47 Bn |
| Sep 30, 2023 | 20.87 Bn |
| Jun 30, 2023 | 20.84 Bn |
| Mar 31, 2023 | 20.93 Bn |
| Dec 31, 2022 | 21.07 Bn |
| Sep 30, 2022 | 19.18 Bn |
| Jun 30, 2022 | 19.81 Bn |
| Mar 31, 2022 | 20.45 Bn |
| Dec 31, 2021 | 20.49 Bn |
| Sep 30, 2021 | 21.14 Bn |
| Jun 30, 2021 | 21.21 Bn |